IVD Market Trends Report, March 2023

IVD Market Trends Report, March 2023

Diagnostic testing continues to be a valuable resource to help physicians arrive at a diagnosis. Additionally, it has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. Now, in the aftermath of the COVID-19 pandemic, new products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient. Ultimately, the IVD market remains dynamic, demonstrating constant innovations.

In IVD Market Trends Report, March 2023, Kalorama Information analyses and answers:

  • What’s Driving Growth in the IVD Market since Q1 2022 and into Q1 2023?
  • What Major Trends have been Affecting the Market since Q1 2022 and into Q1 2023?
  • How Has COVID-19 Impacted and Continued to Impact the Market?
  • What Product Trends and New Developments Will Shape the IVD Market?
Kalorama Information continues to be diligent in outlining the IVD market and its rapidly changing landscape. Kalorama Information has been and continues to be superior in accessing the market due to the extensive experience of its analysts and commitment by the company to present the most accurate data available.


  • Worldwide IVD Market – March 2023 Update
    • IVD Market Demand and Growth
      • Table Quarter-by-Quarter Segment Performance Commentary, 2022
      • Table Global In Vitro Diagnostic Sales by Product Market, 2022 ($ million) (Clinical Chemistry; Immunoassays: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
      • Table IVD Segment Performance (Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other), Q1 2022 – Q4 2022 ($MN)
      • Table IVD Segment Performance (Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other), Total Market Value, 2022 ($MN)
      • COVID-19 Diagnostic Markets
        • Table COVID-19 Product Sales — Immunoassay (Antigen, Serology), Molecular, Rapid — 2022 ($ millions)
    • Effect of COVID-19 on Market Segments
      • Table IVD Market excluding and with COVID-19, 2022
      • Table IVD Market Distribution by Segment (COVID-19 Assays and Instruments, IVD Market excluding COVID-19 Assays and Instruments), 2022
      • Table IVD Market by COVID-19 and non-COVID markets, Quarterly Performance, 2022
      • Table Global In Vitro Diagnostic Market – YoY Growth 2021-2022
      • Table Global In Vitro Diagnostic Market – YoY Growth, by Segment (Blood Bank Molecular – NAT Screens, Blood Grouping/Typing, Clinical Chemistry, Coagulation (PT/INR), D-Dimer, Diabetes HbA1c lab, Drugs of Abuse, Hematology – Core Lab, Histology/Cytology, Immuno – Blood Bank Screening, Immuno – Infectious Disease, Microbiology (ID/AST), Microbiology (Molecular), Nucleic Acid Assays/genetic Tests, Other Immunos, POC – OTC Diabetes, POC – OTC Other, POC – Professional/Hospital), 2021-2022
  • Product Trends and New Developments
    • Selected New – Q4 2022 and Q1 2023 - Core IVD Product Launches, Developments and Trends
      • Immunoassay
      • Molecular
      • Personalized Medicine
      • POC
      • Sequencing
    • Selected COVID-19 Developments – Q4 2022 - Q1 2023
      • Table COVID-19 Test Market by Type, Q1-Q4 2022 – COVID-19 Testing Wanes
      • Antigen/Antibody
      • Molecular
  • Top IVD Market Participant Results
    • Selected Competitive Leader Updates
      • Table IVD Segment Growth by Leading Competitors (Abbott Diagnostics, Becton Dickinson, bioMérieux, Danaher, Hologic, QuidelOrtho, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific), Change in Sales, 2021-2022
      • Table Changes in Market Distribution for IVD Sales, 2019-2022 – Roche and Abbott Battle for #1 Spot
      • Table Comparison of Total Diagnostic Sales for Abbott vs Roche 2020-2022 (in millions $)
    • 2022 M&A Activity
      • Table IVD-Relevant M&A Activity, 2022
      • Table Count of IVD Industry M&A Deals by Month, Full Year 2022 and Jan-Feb 2023
    • Abbott Laboratories
      • Table Abbott Corporate Summary
      • Table Abbott Diagnostics Revenue by Segment (Core Laboratory, Molecular, Point-of-Care, Rapid Diagnostics, COVID-19), Full Year 2021 and 2022 $M
    • Becton Dickinson and Co
      • Table Becton Dickinson Corporate Summary
      • Table BD Life Sciences, Revenues by Business FY End September 30, 2021, and 2022 $M
    • bioMérieux SA
      • Table bioMérieux Corporate Summary
      • Table bioMérieux Clinical Applications Segment, Full Year Results, 2021, 2022 € MN
    • Danaher Corporation
      • Table Danaher Corporation Summary
      • Table Danaher Diagnostic Segment Performance, Full Year Results, 2021 ,2022 $M
    • Hologic, Inc.
      • Table Hologic Corporate Summary
      • Table Hologic Diagnostic Segment Performance, Full Year Results, FY 2021 and FY 2022, $M
    • QuidelOrtho Corporation
      • Table QuidelOrtho Corporate Summary
      • Table QuidelOrtho, Full Year Results, by Segment (Immunoassay/Clinical Lab, Molecular Diagnostics, Point-of-Care, Transfusion Medicine) $M (2021, 2022)
    • Roche Diagnostic
      • Table Roche Diagnostic Corporate Summary
      • Table Roche Diagnostics Revenue by Product Group (Core Lab, Diabetes Care, Molecular, Pathology Lab, Point-of-Care), Full Year Results 2021, 2022, CHF MN
    • Siemens Healthineers
      • Table Siemens Healthineers Corporate Summary
      • Table Siemens Diagnostics Revenue, FY 2021 and FY 2022, €MN
    • Sysmex Corporation
      • Table Sysmex Corporate Summary
      • Table Sysmex Revenue by Product Segment (Clinical Chemistry, FCM, Hematology, Hemostasis, Immunochemistry, Urinalysis, Others), FY 2021, 2022 and 2023, JPY MN
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific Corporate Summary
      • Table Thermo Fisher Scientific COVID-19 Response Revenue, 2021 and 2022, by Quarter $B
  • New Opportunities
    • Artificial Intelligence Future Trends
    • At-Home Testing
    • Multiplex Testing
    • Telehealth

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings